Tenaya Therapeutics Inc. (TNYA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tenaya Therapeutics Inc.

    NASDAQ: TNYA · Real-Time Price · USD
    1.40
    0.05 (3.70%)
    At close: Sep 08, 2025, 3:42 PM

    Tenaya Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -111.13M -124.08M -123.67M -72.72M
    Depreciation & Amortization
    		 8.28M 8.69M 6.47M 2.96M
    Stock-Based Compensation
    		 16.5M 15.31M 11.47M 2.95M
    Other Working Capital
    		 -7.35M -2.37M -2.51M -3.86M
    Other Non-Cash Items
    		 3.59M 3.66M 2.16M 1.06M
    Deferred Income Tax
    		 n/a n/a n/a 192K
    Change in Working Capital
    		 -7.93M -5.65M -849K 4.74M
    Operating Cash Flow
    		 -90.5M -102.07M -104.42M -60.81M
    Capital Expenditures
    		 -1.02M -1.24M -20.63M -25.12M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -87.07M -56.64M -140.48M -213.44M
    Sales Maturities Of Investments
    		 89.21M 106.62M 244.75M n/a
    Other Investing Acitivies
    		 17K -25K 8K -213.44K
    Investing Cash Flow
    		 1.13M 48.72M 83.65M -238.56M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a -13K
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 987K 181K 380K 461K
    Financial Cash Flow
    		 47.75M 4.05M 77.77M 208.97M
    Net Cash Flow
    		 -41.62M -49.31M 56.99M -90.41M
    Free Cash Flow
    		 -91.53M -103.31M -125.05M -85.93M

    Add to Watchlist